日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Evaluation of the Antifungal Activity of the Polyphenol Formulation Viroelixir Against Candida albicans

评价多酚制剂 Viroelixir 对白色念珠菌的抗真菌活性

期刊:Antibiotics-Basel
影响因子:4.6
doi:10.3390/antibiotics15040420
Dahdah, Manal; Ettouil, Yasmine; Issa, Hawraa; Koussih, Latifa; Almutairi, Mikhlid H; Rouabhia, Mahmoud; Semlali, Abdelhabib
微生物学
发表日期：2026
文献求助 收藏

Mechanistic Insights into the Anti-Virulence Effects of Viroelixir, a Phenolic Blend from Green Tea and Pomegranate, on Streptococcus mutans

Viroelixir（一种由绿茶和石榴酚类化合物组成的混合物）对变形链球菌抗毒力作用的机制研究

期刊:Antibiotics-Basel
影响因子:4.6
doi:10.3390/antibiotics15040406
Dahdah, Manal; Nimbarte, Vijaykumar D; Rouabhia, Mahmoud; Ettouil, Yasmine; Issa, Hawraa; Koussih, Latifa; Almutairi, Mikhlid H; Semlali, Abdelhabib
发表日期：2026
文献求助 收藏

Repurposing Antimalarials for Oral Cancer: Selective Efficacy of Hydroxychloroquine on Gingival Squamous Cell Carcinoma.

将抗疟药用于口腔癌治疗：羟氯喹对牙龈鳞状细胞癌的选择性疗效。

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms262210994
Baroudi Sana, González Poleo Diego Alejandro, Issa Hawraa, Almutairi Mikhlid H, Semlali Abdelhabib
口腔癌
细胞生物学
发表日期：2025
文献求助 收藏

New Curcumin Analogue (PAC) Inhibits Candida albicans Virulence, Restricts Its Adhesion Potential, and Relieves Oral Epithelial Cell Inflammation and Defense Mechanisms.

新型姜黄素类似物（PAC）抑制白色念珠菌毒力，限制其粘附潜力，并缓解口腔上皮细胞炎症和防御机制

期刊:Antibiotics-Basel
影响因子:4.6
doi:10.3390/antibiotics14050495
Mezni Ghazoua, Issa Hawraa, Dahdah Manal, Poulin Anaïs, Daïch Adam, Alamri Abdulaziz, Rouabhia Mahmoud, Semlali Abdelhabib
细胞生物学
炎症
发表日期：2025
文献求助 收藏

Assessment of Methicillin-Resistant Staphylococcus aureus (MRSA) knowledge and awareness among healthcare workers in South-Lebanon

评估黎巴嫩南部医护人员对耐甲氧西林金黄色葡萄球菌（MRSA）的知识和认识

期刊:Infection Prevention in Practice
影响因子:1.9
doi:10.1016/j.infpip.2025.100451
El Roz, Ali; Chaaban, Taghrid; Issa, Hawraa; Ibrahim, José-Noel; Ezzeddine, Zeinab; Ghssein, Ghassan
发表日期：2025
文献求助 收藏

Combination of Angiotensin (1-7) Agonists and Convalescent Plasma as a New Strategy to Overcome Angiotensin Converting Enzyme 2 (ACE2) Inhibition for the Treatment of COVID-19

血管紧张素（1-7）激动剂与康复者血浆联合应用作为克服血管紧张素转换酶2（ACE2）抑制治疗COVID-19的新策略

期刊:Frontiers in Medicine
影响因子:3
doi:10.3389/fmed.2021.620990
Issa, Hawraa; Eid, Ali H; Berry, Bassam; Takhviji, Vahideh; Khosravi, Abbas; Mantash, Sarah; Nehme, Rawan; Hallal, Rawan; Karaki, Hussein; Dhayni, Kawthar; Faour, Wissam H; Kobeissy, Firas; Nehme, Ali; Zibara, Kazem
ACE2
发表日期：2021
文献求助 收藏